Submitting Next Generation Sequencing Data to the Division of Antiviral Products Guidance for Industry Technical Specifications Document
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 18, 2019
May 5, 2020
4edd1e8a-43c4-4293-b6b8-ac9472e1a619
Related Documents
Submitting Clinical Trial Datasets to Evaluate the Impact of Immunogenicity on the Pharmacokinetics of a Drug
Guidance DocumentJune 18, 2026Center for Drug Evaluation and Research
Submitting Nonclinical Datasets for Evaluation of Rodent Carcinogenicity Studies of Pharmaceuticals
Guidance DocumentMay 1, 2021Center for Drug Evaluation and Research
Submitting Patient-Reported Outcome Data in Cancer Clinical Trials
Guidance DocumentNovember 6, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.